Blood test can detect mutations that cause malaria resistance

08/14/2014 | New Scientist

A study in The New England Journal of Medicine based on an analysis of blood samples of 1,240 people being treated for malaria in Southeast Asia and Africa revealed that detecting mutations in the kelch13 gene can quickly identify who has the resistant form of malaria. The study also found that artemisinin therapy can still eliminate even the most resistant form of malaria if a longer course of treatment is done.

View Full Article in:

New Scientist

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA